Report - ANNEX I OVERVIEW OF ALENDRONATE LITIGATION IN …ec.europa.eu/competition/consultations/2009_pharma/teva_annexes.pdf · agency found Teva's medicine to be substitutable for ... Teva

Please pass captcha verification before submit form